Skip to main content
. 2020 Apr 18;20:113. doi: 10.1186/s12876-020-01236-9

Fig. 3.

Fig. 3

Cumulative incidence of hepatocellular carcinoma based on the achievement of HBsAg seroclearance. No significant difference was observed in the cumulative incidence of HCC between HBsAg seroclearance and sustained HBsAg-positive groups. HCC, hepatocellular carcinoma. P values were determined using log-rank testing